Dynamic Landscape for Cell and Gene Therapy in 2024

2024 is an exciting time to be involved in the cell and gene therapy (CGT) industry. With rapid advancements in science, the industry is on the cusp of industrializing and standardizing the manufacturing and commercialization of CGT products. The future points toward standardized setups and more automated systems. However, the broad nature of the field […]

Cell and Gene Therapy: $27 Billion in Q1-Q3 2023 Funding

The concepts of cell therapy and gene therapy have been investigated for decades, but there were major challenges in the early years. Through incremental progress, and the gradual introduction of enabling tools such as CRISPR and next-generation sequencing (NGS), cell and gene therapy has emerged into a highly active area. There are now many approved […]

This Week in Cell and Gene Therapy: 13 New Developments to Know (October 12, 2022)

With the 2022 Cell & Gene Meeting on the Mesa (#CGMesa22) underway, here’s a look at some notable recent developments in cell and gene therapy featured in the bimonthly newsletter, Cell and Gene Therapy Business Outlook. Myrtelle, a clinical-stage gene therapy company based in Wakefield, MA, and Forge Biologics, a gene therapy contract development and […]

This Week in Cell and Gene Therapy: 11 New Developments to Know (September 12, 2022)

There have been a number of recent developments in cell and gene therapy, as detailed in our bimonthly newsletter, Cell and Gene Therapy Business Outlook. Kite Pharma, a Gilead Company based in Santa Monica, CA, has announced that the European Commission (EC) has granted approval for its chimeric antigen receptor (CAR) T cell therapy Tecartus […]

This Week in Cell and Gene Therapy: 8 New Developments to Know (August 22, 2022)

There have been a number of recent developments in cell and gene therapy, as detailed in our bimonthly newsletter, Cell and Gene Therapy Business Outlook. Prescient Therapeutics, a clinical stage oncology company based in Melbourne, Australia, has signed a five-year manufacturing agreement with Q-Gen Cell Therapeutics, a specialist cell therapy manufacturer based at the QIMR […]

This Week in Cell and Gene Therapy: 10 New Developments to Know (August 9, 2022)

This Week in Cell and Gene Therapy: 10 New Developments to Know (July 11, 2022)

This Week in Cell and Gene Therapy: 14 New Developments to Know (June 27, 2022)

This Week in Cell and Gene Therapy: 12 New Developments to Know (June 13, 2022)

This Week in Cell and Gene Therapy: 14 New Developments to Know (May 23, 2022)